Lexeo Therapeutics
LXEO
LXEO
88 hedge funds and large institutions have $100M invested in Lexeo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
4.9% less ownership
Funds ownership: 89.26% → 84.36% (-4.9%)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
49% less capital invested
Capital invested by funds: $194M → $100M (-$94.2M)
Holders
88
Holding in Top 10
2
Calls
$111K
Puts
$87K
Top Buyers
| 1 | +$6.56M | |
| 2 | +$4.12M | |
| 3 | +$2.86M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.54M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$969K |
Top Sellers
| 1 | -$8.73M | |
| 2 | -$8.13M | |
| 3 | -$5.43M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$2.66M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.31M |